Skip to main content
. 2022 Jan 7;12(1):69. doi: 10.3390/jpm12010069

Table 4.

Results from the feasibility test.

Consultation Item %
Initial consultation Identification of problems 1: 56.7
Drug interactions 32.8
Other problems 44.8
Communication of treatment goals 88.1
Changes in medications 1: 49.3
Deprescribed ≥ 1 drug 46.2
Prescribed ≥ 1 drug 26.2
Dosage change in ≥ 1 drug 26.2
Communicated safety netting in case of ADR 83.6
Patients takes OTC medication:
Yes 34.3
No 43.3
Unknown 19.4
No answer 3.0
Patient has up-to-date medication plan 70.2
Patient obtains medications from a particular pharmacy:
Yes 71.6
No 1.5
Unknown 26.9
Patient reports treatment burden:
Yes 46.3
No 50.8
Unknown 3.0
If yes, interventions to reduce treatment burden:
Yes 28.4
No 11.9
Not possible 16.4
No answer 43.3
Follow-up consultation Patient has up-to-date medication plan 74.0
Medication changes were successful:
Yes 59.3
No 22.2
Unchanged 14.8
No answer 3.7
Onset of new ADRs/symptoms:
Yes 14.8
No 81.5
Unknown 3.7

1 multiple answers possible; ADR—adverse drug reaction; OTC—over the counter.